Latest Breaking News On - Maravai - Page 1 : comparemela.com

Vaccine reagent vendor Maravai draws private equity interest-sources

Maravai LifeSciences Holdings Inc, a provider of capping reagents for COVID-19 vaccines whose shares plunged after the pandemic eased, has attracted private equity interest, people familiar with. | May 16, 2023

New yorkUnited statesThomash leeAnirban senGreg roumeliotisTrey martinMark potterDanaher corpMaravai lifesciences holdings incLifesciences holdings incSan diego basedCarl hullNew york editingMaravai lifesciences holdingsNc stock exchangePress release

Maravai LifeSciences Reports First Quarter 2023 Financial Results

Continued Focus on Expanding Product Portfolio, Market Leadership and Scientific InnovationSAN DIEGO, May 08, 2023 Maravai LifeSciences Holdings, Inc. , a global provider of life science. | May 8, 2023

San diegoUnited statesNorth carolinaTrilink flandersMaravai lifesciencesMaravai lifesciences holdings incNucleic acid productionRna capping technologyVector laboratories incMaravai topco holdingsGlen researchExchange commissionContinued focusExpanding product portfolioMarket leadershipLifesciences holdings

Maravai LifeSciences To Host Earnings Conference Call on Monday, May 8, 2023

SAN DIEGO, April 17, 2023 Maravai LifeSciences, Inc. , a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its first quarter 2023. | April 17, 2023

Maravai lifesciencesMaravai lifesciences incMaravai lifesciences holdingsNc stock exchangePress releaseUarter mrvi us56600d1072

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 2, 2022

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 2, 2022
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Maravai lifesciencesDeb hartmaravai lifesciencesMaravai lifesciences incMaravai lifesciences holdingsMedia contactSara michelmoremacdougallDeb hartmaravai

Maravai LifeSciences Announces Launch of Proposed Secondary Offering of Class A Common Stock by Selling Stockholders

Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced the commencement of a public offering of its Class A common stock by certain selling stockholders. The selling stockholders are offering 15,000,000 shares of Maravai’s Class A common stock pursuant to a registration statement on Form S-1 (the “Registration Statement”) filed with the Securities and Exchange Commission (the “SEC”). The selling stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 2,250,000 shares of Maravai’s Class A common stock. Maravai will not receive any proceeds from the sale of shares by the selling stockholders.

New yorkUnited statesDeb hart maravai lifesciencesSara michelmore macdougallExchange commissionMorgan stanleyProspectus departmentMaravai lifesciences holdings incEquity syndicate prospectus departmentGoldman sachs coMorgan stanley coLifesciences holdingsGoldman sachsAnnual reportMedia contactMaravai lifesciences holdings